Immunology

Natural killer cells have memory

Researchers at the University of Bonn and the Ludwig-Maximilians-Universität of Munich have decoded a new mechanism of how the immune system can specifically attack pigmented cells of the skin. It was previously believed ...

Oncology & Cancer

Cancer can be combated with reprogrammed macrophage cells

Researchers at Karolinska Institutet have generated antibodies that reprogramme a type of macrophage cell in the tumour, making the immune system better able to recognise and kill tumour cells. The study, which is published ...

Diabetes

Rapid-onset diabetes described with anti-PD-1 treatment

(HealthDay)—In a case report published online April 11 in the Journal of Diabetes Investigation, researchers document rapid-onset insulin-dependent diabetes in an Asian patient undergoing treatment with anti-programmed ...

Oncology & Cancer

Taking on melanoma, one cell at a time

Single-cell analysis is a groundbreaking approach now being used across biological fields to explore a common problem: how to study cellular diversity in cell environments with heterogeneous populations. Such diversity can ...

Oncology & Cancer

Team achieves breakthrough in diagnosis of melanoma skin cancer

In collaboration with researchers from UGent, VIB scientists from KU Leuven have revealed a remarkable link between malignant melanoma and a non-coding RNA gene called SAMMSON. The SAMMSON gene is specifically expressed in ...

Oncology & Cancer

'Nano-sensing' drives melanoma cells' invasion

A new study sheds light on how melanoma cells change from benign to malignant, and how the complex interaction between the cells and their surrounding environment affects outcomes of the cancer.

Oncology & Cancer

Scientists identify gene that regulates the growth of melanoma

Yale Cancer Center researchers have identified a gene in melanoma that can dramatically affect the growth of the disease. The findings, published in the journal Cell Reports, provide new insight into how melanoma grows and ...

Oncology & Cancer

Few want to receive skin cancer biopsy results face-to-face

(HealthDay)—For patients with suspected malignant melanoma or squamous cell carcinoma, most patients are happy to receive biopsy results by letter or telephone, according to a research letter published online Feb. 8 in ...

page 7 from 17